Nicholas S. Green

2022

In 2022, Nicholas S. Green earned a total compensation of $6.2M as President and Chief Executive Officer at Peregrine Pharmaceuticals, a 117% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$895,200
Salary$600,000
Stock Awards$4,642,450
Other$44,174
Total$6,181,824

Green received $4.6M in stock awards, accounting for 75% of the total pay in 2022.

Green also received $895.2K in non-equity incentive plan, $600K in salary and $44.2K in other compensation.

Rankings

In 2022, Nicholas S. Green's compensation ranked 489th out of 5,756 executives tracked by ExecPay. In other words, Green earned more than 91.5% of executives.

ClassificationRankingPercentile
All
489
out of 5,756
92nd
Division
Manufacturing
200
out of 3,133
94th
Major group
Chemicals And Allied Products
55
out of 1,419
96th
Industry group
Drugs
43
out of 1,320
97th
Industry
Pharmaceutical Preparations
29
out of 966
97th
Source: SEC filing on August 29, 2022.

Green's colleagues

We found two more compensation records of executives who worked with Nicholas S. Green at Peregrine Pharmaceuticals in 2022.

2022

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

2022

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

News

You may also like